KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Rate (2016 - 2025)

Historic Tax Rate for Halozyme Therapeutics (HALO) over the last 10 years, with Q3 2025 value amounting to 19.97%.

  • Halozyme Therapeutics' Tax Rate rose 29400.0% to 19.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.17%, marking a year-over-year increase of 19200.0%. This contributed to the annual value of 20.29% for FY2024, which is 11300.0% up from last year.
  • Latest data reveals that Halozyme Therapeutics reported Tax Rate of 19.97% as of Q3 2025, which was up 29400.0% from 19.42% recorded in Q2 2025.
  • In the past 5 years, Halozyme Therapeutics' Tax Rate ranged from a high of 24.41% in Q2 2022 and a low of 192.27% during Q3 2021
  • For the 5-year period, Halozyme Therapeutics' Tax Rate averaged around 4.34%, with its median value being 19.22% (2022).
  • As far as peak fluctuations go, Halozyme Therapeutics' Tax Rate crashed by -1924400bps in 2021, and later skyrocketed by 2086500bps in 2022.
  • Halozyme Therapeutics' Tax Rate (Quarter) stood at 21.82% in 2021, then surged by 185bps to 18.49% in 2022, then decreased by -16bps to 15.6% in 2023, then surged by 48bps to 23.12% in 2024, then dropped by -14bps to 19.97% in 2025.
  • Its Tax Rate was 19.97% in Q3 2025, compared to 19.42% in Q2 2025 and 17.89% in Q1 2025.